Showing 81 - 100 of 313 results
Australia’s Open Pool Australian Lightwater (OPAL) reactor is a state-of-the-art 20 megawatt multi-purpose reactor that uses low enriched uranium (LEU) fuel to achieve a range of activities to benefit human health, enable research to support a more sustainable environment and provide innovative solutions for industry.
Frequently asked questions about ANSTO for the community.
ANSTO works in partnerships and collaborative ventures with national and international organisations. Partner with ANSTO.
ANSTO is a unique national science organisation that began operating under its predecessor The Australian Atomic Energy Commission (AAEC) 70 years ago.
ANSTO is a major supplier of Australia’s radioactive isotopes used in nuclear medicine, delivering around 10,000 patient doses each week. Health-based research and development in Australia and overseas also benefit greatly from ANSTO’s unique capabilities and expertise in the detection, diagnosis and treatment of disease using nuclear and accelerator infrastructure.
Science and medical experts meet in Adelaide to discuss great potential of particle therapy in Australia
Director of the Australian Synchrotron Prof Andrew Peele has been appointed to Australian Mathematical Sciences Board.
Australian-first detector to accelerate cancer research unveiled.
Two of Australia’s leading science organisations, ANSTO and the National Measurement Institute (NMI), which share areas of common interest in both measurement and research, signed a MOU formalising collaboration on 6 March 2019.
Letter to Editor of the Sydney Morning Herald following publication of news report
ANSTO physicist will gain further experience in particle therapy technologies.
The new trilateral security partnership between Australia, the UK and the US (AUKUS) is a historically significant development for nuclear science and technology in Australia.